Shoulder Innovations (NYSE:SI) Director Richard Buchholz Acquires 1,000 Shares of Stock

Shoulder Innovations, Inc. (NYSE:SI) Director Richard Buchholz purchased 1,000 shares of Shoulder Innovations stock in a transaction that occurred on Friday, March 13th. The shares were bought at an average cost of $14.84 per share, for a total transaction of $14,840.00. Following the completion of the transaction, the director directly owned 13,666 shares in the company, valued at $202,803.44. This represents a 7.90% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available through this link.

Shoulder Innovations Trading Down 0.5%

SI opened at $15.20 on Wednesday. The firm’s 50 day moving average is $13.76 and its 200-day moving average is $13.85. Shoulder Innovations, Inc. has a 52-week low of $10.92 and a 52-week high of $17.94. The company has a quick ratio of 9.55, a current ratio of 11.07 and a debt-to-equity ratio of 0.11. The firm has a market capitalization of $313.88 million and a P/E ratio of -0.07.

Shoulder Innovations (NYSE:SI) last announced its earnings results on Tuesday, March 10th. The company reported ($0.38) earnings per share for the quarter, beating the consensus estimate of ($0.42) by $0.04. Shoulder Innovations had a negative net margin of 85.29% and a negative return on equity of 37.68%. The business had revenue of $14.42 million during the quarter, compared to the consensus estimate of $12.69 million. Analysts expect that Shoulder Innovations, Inc. will post -0.56 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of SI. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of Shoulder Innovations in the 3rd quarter worth approximately $28,000. Rhumbline Advisers bought a new position in Shoulder Innovations during the third quarter worth $54,000. Wells Fargo & Company MN boosted its holdings in Shoulder Innovations by 66.3% in the fourth quarter. Wells Fargo & Company MN now owns 5,250 shares of the company’s stock worth $75,000 after purchasing an additional 2,094 shares during the period. Board of Trustees of The Leland Stanford Junior University bought a new stake in Shoulder Innovations during the third quarter valued at $170,000. Finally, Renaissance Technologies LLC acquired a new stake in shares of Shoulder Innovations during the fourth quarter worth $176,000.

Analysts Set New Price Targets

A number of brokerages recently commented on SI. Morgan Stanley increased their price target on Shoulder Innovations from $18.00 to $23.00 and gave the company an “overweight” rating in a report on Tuesday, December 2nd. BTIG Research upped their target price on Shoulder Innovations from $23.00 to $24.00 and gave the company a “buy” rating in a research report on Wednesday, March 11th. Weiss Ratings reissued a “sell (e)” rating on shares of Shoulder Innovations in a research report on Monday, December 29th. Finally, The Goldman Sachs Group reaffirmed a “buy” rating on shares of Shoulder Innovations in a report on Friday, January 9th. Five equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $20.80.

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.